SARS CoV 2 News and Research

RSS

Moderna COVID-19 vaccine effective in children five and under

mRNA-1273 vaccine (Moderna) shows strong effectiveness in reducing symptomatic SARS-CoV-2 infection and COVID-19-related hospitalization in children aged 6 months to 5 years. Further research is needed to explore long-term effectiveness and the potential need for booster doses.

5 Jul 2023

Study sheds light on the long-term effects of COVID-19 on minority groups

A new study conducted by researchers at Bar-Ilan University in Israel has shed light on the long-term impact of COVID-19 on the quality of life among different ethnic groups in the country. The study, part of a larger cohort project, highlights a significant discrepancy between Arabs and Druze, and Jews, with the two former groups experiencing a more pronounced decline in quality of life one year after infection.

5 Jul 2023

Beyond the lungs: SARS-CoV-2's multi-organ impact revealed

Researchers present the mechanisms by which SARS-CoV-2 could infect the brain and affect memory.

5 Jul 2023

SYS6006 investigational COVID-19 mRNA vaccine shows promise as fourth dose booster

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 600 million confirmed cases and 6.5 million deaths worldwide.

4 Jul 2023

Immune inflammatory reaction to COVID-19 may not be the underlying cause of long Covid

Long Covid, which affects nearly two-million people in the UK, is not caused by an immune inflammatory reaction to COVID-19, University of Bristol-led research finds.

4 Jul 2023

Was there a change in the incidence of diabetes in children and adolescents after the onset of the COVID-19 pandemic?

Study compares the incidence rates of pediatric T1D and 2D during and before SARS-CoV-2.

4 Jul 2023

Wastewater surveillance highlights significant underestimation of COVID-19 cases in Canada

Research examines the correlation between SARS-CoV-2 levels in untreated water and COVID-19 cases and hospitalizations in Ontario, Canada. It also highlights the value of wastewater data in enhancing local decision-making and COVID-19 surveillance systems.

3 Jul 2023

Does COVID-19 increase the risk of bacterial infections in infants?

Researchers assess the prevalence of bacterial meningitis, bacteremia, and urinary tract infections among infants tested for viral infections.

3 Jul 2023

AI predicts on- and off-target activity of RNA-targeting CRISPRs

Artificial intelligence can predict on- and off-target activity of CRISPR tools that target RNA instead of DNA, according to new research published in Nature Biotechnology.

3 Jul 2023

Precision protection: antibody testing offers insights into predicting SARS-CoV-2 infection risk in immunocompromised patients

Researchers used antibody testing to predict the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

3 Jul 2023

New COVID-19 mRNA vaccine is safe and highly immunogenic as a heterologous booster: Study

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 600 million confirmed cases and 6.5 million deaths worldwide.

3 Jul 2023

COVID-19 severity linked to autoantibodies against blood clotting protein

Study investigates the occurrence of ADAMTS13 antibodies in COVID-19 patients and their association with disease severity and lower ADAMTS13 activity. The findings suggest the need to include ADAMTS13 antibodies in diagnosing and managing SARS-CoV-2 infections.

2 Jul 2023

SARS CoV 2 News and Research

Moderna COVID-19 vaccine effective in children five and under

Study sheds light on the long-term effects of COVID-19 on minority groups

Beyond the lungs: SARS-CoV-2's multi-organ impact revealed

SYS6006 investigational COVID-19 mRNA vaccine shows promise as fourth dose booster

Immune inflammatory reaction to COVID-19 may not be the underlying cause of long Covid

Was there a change in the incidence of diabetes in children and adolescents after the onset of the COVID-19 pandemic?

Wastewater surveillance highlights significant underestimation of COVID-19 cases in Canada

Does COVID-19 increase the risk of bacterial infections in infants?

AI predicts on- and off-target activity of RNA-targeting CRISPRs

Precision protection: antibody testing offers insights into predicting SARS-CoV-2 infection risk in immunocompromised patients

New COVID-19 mRNA vaccine is safe and highly immunogenic as a heterologous booster: Study

COVID-19 severity linked to autoantibodies against blood clotting protein

20 years later: lessons from SARS-CoV-2 inform preparedness against future pandemics

Study identifies the predictors of post-coronavirus disease 2019 (COVID-19) syndrome symptoms

Beyond diagnosis: coping strategies and their influence on Parkinson's patients' well-being

Has COVID-19 changed the future of pharmaceutical regulation?

Long COVID cannot be treated as a single condition, study says

Researchers screen 16 UK native bat species for coronaviruses with zoonotic potential

Study suggests blood group A may directly influence SARS-CoV-2 infectious risk

Understanding the biological effects of SARS-CoV-2 persistence in children

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News